Holen Sie sich die Stockscreener-App
230.05
1.46%
3.32
Handel nachbörslich:
230.05
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Finanzdaten der Resmed Inc-Aktie (RMD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
2.25%
1,463.65
|
1,431.41 | 1,422.81 | 1,335.58 | 1,347.99 |
| Cost Of Revenue |
11.47%
602.43
|
540.43 | 544.08 | 514.76 | 527.92 |
| Gross Profit |
3.34%
861.22
|
890.98 | 878.72 | 820.82 | 820.07 |
Operating Expenses
|
5.45%
412.51
|
391.17 | 387.06 | 374.28 | 365.53 |
| Operating Income/Loss |
10.22%
448.71
|
499.81 | 491.66 | 446.54 | 454.54 |
| Nonoperating Income/Loss |
917.27%
25.45
|
2.502 | 4.488 | 0.256 | 3.513 |
| Income/Loss From Equity Method Investments |
29.98%
2.233
|
1.718 | 1.515 | 1.489 | 1.269 |
| Income/Loss From Continuing Operations Before Tax |
5.60%
474.16
|
502.31 | 496.15 | 446.79 | 458.05 |
| Income Tax Expense/Benefit |
12.40%
90.73
|
103.58 | 103.56 | 98.26 | 78.35 |
| Net Income/Loss |
3.84%
383.43
|
398.73 | 392.59 | 348.54 | 379.70 |
| Common Stock Dividends |
0.00%
0.60
|
0.60 | 0.60 | 0.60 | 0.53 |
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):